A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 22, 2018 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: 2017--Some Good Things Happened and Some Others Allen Loyd V Jr	Jan/Feb 2018 Pg. 4
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Pain: Systematic Review of Pharmacy Compounding of Pain Medication Shawaqfeh Mohammad S, Harrington Catherine	Jan/Feb 2018 Pg. 19-24
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Blankenship Cynthia	Jan/Feb 2018 Pg. 26-28
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients McElhiney Linda F	Jan/Feb 2018 Pg. 30-39
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Kosinski Tracy M, Brown Michael C, Zavala Pedro J	Jan/Feb 2018 Pg. 41-46
Calculations Stockton Shelly J	Jan/Feb 2018 Pg. 48
Glutamate and Aspartate Cardioplegia Additive Solution Allen Loyd V Jr	Jan/Feb 2018 Pg. 50
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Metronidazole 50 mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 52
Miconazole 10% in Recura Topical Cream Allen Loyd V Jr	Jan/Feb 2018 Pg. 53
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Sodium Citrate 9% Nasal Spray for Olfactory Disorders Allen Loyd V Jr	Jan/Feb 2018 Pg. 57
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Voriconazole 40-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 59
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Song Guiyun, Banov Daniel, Bassani August S	Jan/Feb 2018 Pg. 60-65
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H	Jan/Feb 2018 Pg. 66-75
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Pharmacogenomics: Precision Pharmacy in 503A Compounding Drummond Joseph, Bennet Daron, Allen Loyd V Jr	Mar/Apr 2018 Pg. 95-107
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Blankenship Cynthia	Mar/Apr 2018 Pg. 125-126
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Rhoads Rick	Mar/Apr 2018 Pg. 129-134
Basics of Compounding: Compounding Microemulsions Allen Loyd V Jr	Mar/Apr 2018 Pg. 137-143
Calculations Stockton Shelly J	Mar/Apr 2018 Pg. 144
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Allen Loyd V Jr	Mar/Apr 2018 Pg. 146
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Allen Loyd V Jr	Mar/Apr 2018 Pg. 147
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 148
Levodopa and Carbidopa Rectal Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 149
Prochlorperazine Edisylate 0.5% Nasal Spray Allen Loyd V Jr	Mar/Apr 2018 Pg. 150
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Allen Loyd V Jr	Mar/Apr 2018 Pg. 151
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Allen Loyd V Jr	Mar/Apr 2018 Pg. 153
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini	Mar/Apr 2018 Pg. 154-163
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei	Mar/Apr 2018 Pg. 164-171
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
PreScription: Influence and Sphere of Influence Allen Loyd V Jr	May/Jun 2018 Pg. 180
Pitch Ointment: Applications in Scar and Wound Management Kloesel Lawson, Carvalho Maria, Banov Fabiana	May/Jun 2018 Pg. 182-188
Establishing a Rationale for Compounding Hormone Replacement Therapy Biundo Bruce	May/Jun 2018 Pg. 190-195
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Agbi Kelechi E, Hover Sara, Carvalho Maria	May/Jun 2018 Pg. 196-202
Your Presence is Needed at Compounders on Capitol Hill! Blankenship Cynthia	May/Jun 2018 Pg. 204-205
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Allen Loyd V Jr	May/Jun 2018 Pg. 206-217
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Allen Loyd V Jr	May/Jun 2018 Pg. 220-228
Calculations Stockton Shelly J	May/Jun 2018 Pg. 230
Anhydrous Silicon Base Topical Gel Vehicle Allen Loyd V Jr	May/Jun 2018 Pg. 232
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Dorzolamide 2% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2018 Pg. 234
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 235
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 236
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Allen Loyd V Jr	May/Jun 2018 Pg. 237
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 238
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 239
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Khokhlova Kateryna O, Zdoryk Oleksandr A	May/Jun 2018 Pg. 240-246
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J	May/Jun 2018 Pg. 247-251
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa	May/Jun 2018 Pg. 252-256
Trace Level Analysis of Airborne Hormone Particulates Trimble John O, Hampton Shanna	May/Jun 2018 Pg. 257-263
Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension	May/Jun 2018 Pg. 263
PreScription: Factors Related to Drug Waste and Pharmacy Solutions Allen Loyd V Jr	Jul/Aug 2018 Pg. 268
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don	Jul/Aug 2018 Pg. 270-278
Compounding from a Pharmacy Student's Perspective Gochenauer Alexandria	Jul/Aug 2018 Pg. 281-283
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Williams LaVonn	Jul/Aug 2018 Pg. 284-287
Quality Control: Water Activity Considerations for Beyond-use Dates Allen Loyd V Jr	Jul/Aug 2018 Pg. 288-293
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Allen Loyd V Jr	Jul/Aug 2018 Pg. 294-300
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Martin Matt	Jul/Aug 2018 Pg. 303-312
Calculations Stockton Shelly J	Jul/Aug 2018 Pg. 314
Anhydrous Medium-chain Triglycerides Gel Allen Loyd V Jr	Jul/Aug 2018 Pg. 316
Budesonide 1-mg//10-mL Mucolox Oral Suspensions Allen Loyd V Jr	Jul/Aug 2018 Pg. 317
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 318
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jul/Aug 2018 Pg. 319
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 320
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Allen Loyd V Jr	Jul/Aug 2018 Pg. 321
Minoxidil 50 mg/mL in Espumil Foam Base Allen Loyd V Jr	Jul/Aug 2018 Pg. 322
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Allen Loyd V Jr	Jul/Aug 2018 Pg. 323
Pentoxifylline 5% in Dermabase Allen Loyd V Jr	Jul/Aug 2018 Pg. 324
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 325
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J	Jul/Aug 2018 Pg. 326-328
Kinetics of Tetracaine Solvolysis in Propylene Glycol McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M	Jul/Aug 2018 Pg. 329-334
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M	Jul/Aug 2018 Pg. 335-339
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes Huffman Jessica, Brown Stacy, Lewis Paul, Lawson Sarah, Ogle Amanda, Peacock Gina	Jul/Aug 2018 Pg. 340-344
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam	Jul/Aug 2018 Pg. 345-349
PreScription: Updating Formulations Allen Loyd V Jr	Sep/Oct 2018 Pg. 356
Current Trends and Emerging Priorities in Compounded Preparations for Children Parrish Richard H II	Sep/Oct 2018 Pg. 358-366
Certification of Powder-containment Hoods for Nonsterile Compounding Mulder Kyle, Dozzi Raphael	Sep/Oct 2018 Pg. 369-384
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin	Sep/Oct 2018 Pg. 387-398
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
Calculations Stockton Shelly J	Sep/Oct 2018 Pg. 406
Cysteamine 0.5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2018 Pg. 408
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	Sep/Oct 2018 Pg. 409
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Allen Loyd V Jr	Sep/Oct 2018 Pg. 410
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Stability of Tranexamic Acid Mouth Rinse Donnelly Ronald F	Sep/Oct 2018 Pg. 412-416
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Nalenz Heiko, Köpf Ellen, Dietel Elke	Sep/Oct 2018 Pg. 417-423
A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha	Sep/Oct 2018 Pg. 424-432
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R	Sep/Oct 2018 Pg. 433-439
PreScription: Standardized Concentrations: Pro or Con? Allen Loyd V Jr	Nov/Dec 2018 Pg. 444
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Zur Eyal	Nov/Dec 2018 Pg. 446-454
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Riepl Mike	Nov/Dec 2018 Pg. 456-465
Case Study: Absorption of Testosterone Cream via Scrotal Delivery Needham Shawn, Needham Shane	Nov/Dec 2018 Pg. 466-468
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy Waldschmidt Ryan	Nov/Dec 2018 Pg. 471-473
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Martin Matt	Nov/Dec 2018 Pg. 475-478
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Cutaia Kara, Chablani Lipika, Zhao Fang	Nov/Dec 2018 Pg. 480-489
Calculations Stockton Shelly J	Nov/Dec 2018 Pg. 490
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 492
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Hydrocortisone 2 mg/mL in Inorpha Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 495
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Prednisone 5 mg/mL ir Oral Mix Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 497
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer	Nov/Dec 2018 Pg. 498-503
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel	Nov/Dec 2018 Pg. 504-511
Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa	Nov/Dec 2018 Pg. 512-515
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Errata Allen Loyd V Jr	Nov/Dec 2018 Pg. 527
Return to Top